13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...8, 9, 10, 11, 12, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-09-26
4:54 pm
Purchase
2022-09-14 13G POINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P 5,590,048
5.400%
2,669,522increase
(+91.41%)
Filing
History
2022-08-26
5:11 pm
Purchase
2022-08-16 13G Vigil Neuroscience, Inc.
VIGL
BIOTECHNOLOGY VALUE FUND L P 2,739,727
7.500%
2,739,727increase
(New Position)
Filing
History
2022-08-23
4:45 pm
Purchase
2022-08-22 13D Kymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P 4,692,604
8.600%
553,846increase
(+13.38%)
Filing
History
2022-08-11
4:48 pm
Purchase
2022-08-09 13D CTI BioPharma Corp.
CTIC
BIOTECHNOLOGY VALUE FUND L P 28,463,021
19.990%
11,339,998increase
(+66.23%)
Filing
History
2022-07-29
4:37 pm
Purchase
2022-07-27 13G CytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P 6,595,801
10.100%
792,101increase
(+13.65%)
Filing
History
2022-07-19
5:13 pm
Sale
2022-07-15 13G ContraFect Corporation
CFRX
BIOTECHNOLOGY VALUE FUND L P 23,091
4.500%
-26,563decrease
(-53.50%)
Filing
History
2022-07-12
4:40 pm
Purchase
2022-07-08 13G ESSA Pharma Inc.
EPIX
BIOTECHNOLOGY VALUE FUND L P 8,748,629
19.900%
4,183,387increase
(+91.64%)
Filing
History
2022-07-11
5:03 pm
Purchase
2022-06-29 13G 89bio, Inc.
ETNB
BIOTECHNOLOGY VALUE FUND L P 3,898,000
9.990%
3,898,000increase
(New Position)
Filing
History
2022-06-21
4:53 pm
Purchase
2022-06-16 13G 4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P 4,007,413
12.400%
2,001,551increase
(+99.79%)
Filing
History
2022-06-16
5:24 pm
Purchase
2022-06-06 13G Centessa Pharmaceuticals plc
CNTA
BIOTECHNOLOGY VALUE FUND L P 6,894,345
7.300%
6,894,345increase
(New Position)
Filing
History
2022-06-06
5:25 pm
Purchase
2022-06-02 13G Repare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P 8,141,988
19.400%
3,283,227increase
(+67.57%)
Filing
History
2022-06-01
5:00 pm
Purchase
2022-05-27 13D Kymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P 4,138,758
8.000%
552,100increase
(+15.39%)
Filing
History
2022-05-26
5:09 pm
Purchase
2022-05-16 13G Annexon, Inc.
ANNX
BIOTECHNOLOGY VALUE FUND L P 3,343,194
8.700%
3,343,194increase
(New Position)
Filing
History
2022-05-02
5:02 pm
Purchase
2022-04-22 13G iTeos Therapeutics, Inc.
ITOS
BIOTECHNOLOGY VALUE FUND L P 1,929,201
5.400%
1,929,201increase
(New Position)
Filing
History
2022-05-02
4:59 pm
Purchase
2022-04-22 13G IDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P 1,964,859
5.100%
1,964,300increase
(+351395.35%)
Filing
History
2022-04-18
4:49 pm
Purchase
2022-04-05 13D MoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P 21,751,284
58.900%
21,751,284increase
(New Position)
Filing
History
2022-04-04
4:38 pm
Purchase
2022-03-25 13G AN2 Therapeutics, Inc.
ANTX
BIOTECHNOLOGY VALUE FUND L P 1,616,665
8.600%
1,616,665increase
(New Position)
Filing
History
2022-03-24
4:22 pm
Purchase
2022-03-14 13G Tyra Biosciences, Inc.
TYRA
BIOTECHNOLOGY VALUE FUND L P 2,472,327
5.900%
2,472,327increase
(New Position)
Filing
History
2022-03-18
7:18 pm
Sale
2021-12-31 13G Xenon Pharmaceuticals Inc.
XENE
BIOTECHNOLOGY VALUE FUND L P 4,305,540
8.200%
-851,946decrease
(-16.52%)
Filing
History
2022-03-14
4:48 pm
Purchase
2022-03-03 13G Arcus Biosciences, Inc.
RCUS
BIOTECHNOLOGY VALUE FUND L P 3,960,948
5.600%
1,208,726increase
(+43.92%)
Filing
History
Goto Prev, 0, 1, ...8, 9, 10, 11, 12, ...17, 18, Next